Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
August 1, 2024
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites
Lixin Zhang, Mary Strange, Esther Elishaev, et al.
Optics Letters
|
September 16, 2009
Possible mechanism for laser-induced two-dimensional periodic structures by analogy with the Bénard effect
I Ursu, I A Dorobantu, I N Mihailescu, et al.
Plos One
|
August 1, 2014
MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location
Tejas S Tirodkar, Raluca A Budiu, Esther Elishaev, et al.
Cancer Immunology, Immunotherapy : CII
|
April 5, 2011
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
Raluca A Budiu, Gina Mantia-Smaldone, Esther Elishaev, et al.
Cancers
|
November 26, 2022
Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy
Adria Suarez Mora, Mary Strange, Yusi Fang, et al.
Brain, Behavior, and Immunity
|
March 24, 2011
Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton
Melanie S Flint, Raluca A Budiu, Pang-ning Teng, et al.
Molecular Pharmaceutics
|
December 24, 2014
Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model
Meltem Ocak, Andrea G Gillman, Jamee Bresee, et al.
Cancer Immunology, Immunotherapy : CII
|
May 23, 2015
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model
Jyothi Thyagabhavan Mony, Lixin Zhang, Tianzhou Ma, et al.
Oncoimmunology
|
April 17, 2023
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
Paul G Pavicic, Patricia A Rayman, Shadi Swaidani, et al.
Oncogene
|
August 17, 2018
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin, Shauna N Vasilatos, Lin Chen, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
August 1, 2024
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites
Lixin Zhang, Mary Strange, Esther Elishaev, et al.
Optics Letters
|
September 16, 2009
Possible mechanism for laser-induced two-dimensional periodic structures by analogy with the Bénard effect
I Ursu, I A Dorobantu, I N Mihailescu, et al.
Plos One
|
August 1, 2014
MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location
Tejas S Tirodkar, Raluca A Budiu, Esther Elishaev, et al.
Cancer Immunology, Immunotherapy : CII
|
April 5, 2011
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
Raluca A Budiu, Gina Mantia-Smaldone, Esther Elishaev, et al.
Cancers
|
November 26, 2022
Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy
Adria Suarez Mora, Mary Strange, Yusi Fang, et al.
Brain, Behavior, and Immunity
|
March 24, 2011
Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton
Melanie S Flint, Raluca A Budiu, Pang-ning Teng, et al.
Molecular Pharmaceutics
|
December 24, 2014
Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model
Meltem Ocak, Andrea G Gillman, Jamee Bresee, et al.
Cancer Immunology, Immunotherapy : CII
|
May 23, 2015
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model
Jyothi Thyagabhavan Mony, Lixin Zhang, Tianzhou Ma, et al.
Oncoimmunology
|
April 17, 2023
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
Paul G Pavicic, Patricia A Rayman, Shadi Swaidani, et al.
Oncogene
|
August 17, 2018
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin, Shauna N Vasilatos, Lin Chen, et al.
Page
of 10